MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-03-03 for PELVIC MESH manufactured by Unk.
[182387157]
Add'l surgeries; i was implanted with pelvic mesh for a cystocele and rectocele repair as well as a bladder sling. I've had multiple revision surgeries because of pain and other symptoms from mesh extrusion. I'm a masters educated nurse and have lost my job, my health, and my future. I am totally disabled and unable to work since 2011. I went from incredibly healthy to disabled within 6 years with my health rapidly decreasing from implant onwards. I am now facing a life-threatening and expensive surgery to attempt to remove all of the mesh. It has been an absolute nightmare. I'm only (b)(6) and i've lost the last 10-15 years of my life to this mesh. I have autoimmune diseases that i believe were brought on by the chronic inflammation and infection of my mesh. Fda safety report id# (b)(4).
Patient Sequence No: 1, Text Type: D, B5
Report Number | MW5093510 |
MDR Report Key | 9786049 |
Date Received | 2020-03-03 |
Date of Report | 2020-02-29 |
Date of Event | 2005-09-18 |
Date Added to Maude | 2020-03-04 |
Event Key | 0 |
Report Source Code | Voluntary report |
Manufacturer Link | N |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Reporter Occupation | PATIENT |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | PELVIC MESH |
Generic Name | MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN |
Product Code | PAI |
Date Received | 2020-03-03 |
Device Availability | Y |
Device Eval'ed by Mfgr | I |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | UNK |
Manufacturer Address | UNK UNK |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Hospitalization; 2. Other; 3. Deathisabilit | 2020-03-03 |